Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Non-Current Debt (2017 - 2025)

Catheter Precision (VTAK) has disclosed Non-Current Debt for 7 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Non-Current Debt fell 14.8% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 14.8% year-over-year, with the annual reading at $1.3 million for FY2025, 14.8% down from the prior year.
  • Non-Current Debt for Q4 2025 was $1.3 million at Catheter Precision, up from $1.3 million in the prior quarter.
  • The five-year high for Non-Current Debt was $9.6 million in Q2 2023, with the low at $1.3 million in Q2 2025.
  • Average Non-Current Debt over 3 years is $4.6 million, with a median of $1.6 million recorded in 2024.
  • Peak annual rise in Non-Current Debt hit 14.8% in 2025, while the deepest fall reached 14.8% in 2025.
  • Over 3 years, Non-Current Debt stood at $8.8 million in 2023, then tumbled by 82.36% to $1.6 million in 2024, then dropped by 14.8% to $1.3 million in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $1.3 million, $1.3 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.